Previous 10 | Next 10 |
Ardelyx Reports Third Quarter 2021 Financial Results PR Newswire FREMONT, Calif. and WALTHAM, Mass. , Nov. 12, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of ...
Ardelyx to Present at the Jefferies London Healthcare Conference PR Newswire FREMONT, Calif. and WALTHAM, Mass. , Nov. 11, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and comme...
Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021 - First patient reported outcome data on tenapanor from OPTIMIZE trial demonstrates improved overall patient experience and benefit of one pill twice daily dosing regimen ...
Ardelyx to Pursue Formal Dispute Resolution for Tenapanor Ardelyx maintains that in its comprehensive development program, tenapanor has demonstrated clinical relevance for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis PR Newswire ...
Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021 Data to provide insights on long term safety and efficacy of tenapanor in controlling serum phosphorus in patients with CKD on dialysis PR Newswire FREMONT, Calif. and WALTHAM, Mass. , ...
Ardelyx did not get much clarity from the Type A meeting. Tenapanor's future remains unclear. Prices are low, and I may buy some shares if only I can promise myself I can forget about them. For further details see: Ardelyx: Indecisive Regulators, Frustrated Company, Grue...
Gainers: Jasper (NASDAQ:JSPR) +127%. Waitr Holdings (NASDAQ:WTRH) +55%. Clarus Therapeutics Holdings (NASDAQ:CRXT) +46%. Sono-Tek (NASDAQ:SOTK) +26%. Paltalk (NASDAQ:PALT) +21%. Statera Biopharma (NASDAQ:STAB) +20%. SMART Global Holdings (NASDAQ:SGH) +15%. NeuroBo Pharmaceuticals (NASDAQ:NRBO...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s loads of hot penny stocks worth checking in on today and we’re taking a look at what some of the top movers are doing! Source: Shutterstock Let’s jump right into that penny stock news be...
Gainers: Jasper Therapeutics JSPR +114%, Clarus Therapeutics (NASDAQ:CRXT) +45%, Alimera Sciences ALIM +19%, Revance Therapeutics RVNC +13%, Recursion Pharmaceuticals (NASDAQ:RXRX) +12%. Losers: NeuroOne Medical Technologies NMTC -25%, Ne...
Ardelyx Provides Corporate Update Following Type A Meeting with FDA - Despite Type A Meeting, Ardelyx continues to await clarity from FDA on path forward for approval of tenapanor for hyperphosphatemia - Company reduces staff by 65% PR Newswire FREMONT, Calif. ...
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...